Document:

EX-10.2.5

 Exhibit 10.2.5 
 RESTRICTED STOCK UNIT AGREEMENT 
 This Restricted Stock Unit Agreement
(this “Agreement”) is made and entered into as of August 8, 2013 (the “Grant Date”) by and between Biocept, Inc., a Delaware corporation (the “Company”) and [DIRECTOR NAME] (the
“Grantee”). 
 WHEREAS, the Company has adopted the Biocept, Inc. 2013 Equity Incentive Plan (the
“Plan”) pursuant to which awards of Restricted Stock Units may be granted; and 
 WHEREAS, the
Committee (or the Board) has determined that it is in the best interests of the Company and its stockholders to grant the award of Restricted Stock Units provided for herein, and accordingly has so granted. 

NOW, THEREFORE, the parties hereto, intending to be legally bound, agree as follows: 

1. Grant of Restricted Stock Units. 
 1.1 Pursuant to Section 7.2 of the Plan, the Company hereby issues to the Grantee on the Grant Date an Award consisting of, in the aggregate, [NUMBER] Restricted Stock Units (the
“Restricted Stock Units”). Each Restricted Stock Unit represents the right to receive one share of Common Stock, subject to the terms and conditions set forth in this Agreement and the Plan. Capitalized terms that are used but not
defined herein have the meaning ascribed to them in the Plan. 
 1.2 The Restricted Stock Units shall be credited to the
Grantee on the books and records of the Company. All amounts credited to the Grantee shall continue for all purposes to be part of the general assets of the Company. 
 2. Consideration. The grant of the Restricted Stock Units is made in consideration of the services to be rendered by the Grantee to the Company. 

3. Vesting. 
 3.1 Except
as otherwise provided herein, provided that the Grantee remains in Continuous Service through the applicable vesting date, the Restricted Stock Units will vest in accordance with the following schedule: 

 

					
	Vesting Date	  	Number of Restricted
Stock Units That Vest	 
	 The last day of each calendar month beginning August 2013
	  	 	8.333	% 

 Once vested, the Restricted Stock Units become “Vested Units.” 

3.2 Except as provided in the next sentence, if the Grantee’s Continuous Service terminates for any reason at any time before all of
his or her Restricted Stock Units have vested, the Grantee’s unvested Restricted Stock Units (except for unvested Restricted Stock Units which vest simultaneously with such termination) shall be automatically forfeited upon such termination of
Continuous Service and neither the Company nor any Affiliate shall have any further obligations to the Grantee with respect to such unvested Restricted Stock Units. 
 The foregoing vesting schedule notwithstanding, (a) if the Grantee’s Continuous Service terminates as a result of the Grantee’s death, Disability, a termination by the Company or an
Affiliate without Cause or a termination by the Grantee for Good Reason, then (subject to Section 10.2) 100% of the unvested Restricted Stock Units shall vest as of the date of such termination, and (b) if a Change in Control occurs
during the Grantee’s Continuous Service, then (subject to Section 10.2) 100% of the unvested Restricted Stock Units shall vest as of the date of such Change in Control. 
 4. Restrictions. Subject to any exceptions set forth in this Agreement or the Plan, from the Grant Date until such time as the Restricted Stock Units are settled in accordance with
Section 6, the Restricted Stock Units or the rights relating thereto may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Grantee. Any attempt to assign, alienate, pledge, attach, sell or
otherwise transfer or encumber the Restricted Stock Units or the rights relating thereto shall be wholly ineffective and, if any such attempt is made, the Restricted Stock Units will be forfeited by the Grantee and all of the Grantee’s rights
to such units shall immediately terminate without any payment or consideration by the Company. 
 5. Rights as Stockholder. 

5.1 The Grantee shall not have any rights of a stockholder with respect to the shares of Common Stock underlying the Restricted Stock
Units unless and until and except to the extent that (a) such Restricted Stock Units have become Vested Units and (b) such Vested Units are settled by the issuance of shares of Common Stock. 

5.2 Upon and following the settlement of the Vested Units, the Grantee shall be the record owner of the shares of Common Stock which had
underlain the Vested Units unless and until such shares are sold or otherwise disposed of, and as record owner shall be entitled to all rights of a stockholder of the Company (including voting rights). 

6. Settlement of Restricted Stock Units. 
 6.1 Subject to Section 9 hereof, promptly following the Trigger Date, the Company shall (a) issue and deliver to the Grantee the number of shares of Common Stock equal to

  
 2 

 
the number of Vested Units; and (b) enter the Grantee’s name on the books of the Company as the stockholder of record with respect to the shares of Common Stock delivered to the
Grantee. The “Trigger Date” means the earliest of (a) May 24, 2015, (b) the date of a Change in Control (but only in the event that the Change in Control is an event described in Section 409A(a)(2)(A)(v) of the
Code and the regulations and other guidance promulgated thereunder), (c) the date the Grantee’s Continuous Service terminates as a result of the Grantee’s Disability (but only, in such case, in the event that such termination of
Continuous Service is due to the Grantee becoming “disabled” as described in Section 409A(a)(2)(C) of the Code and the regulations and other guidance promulgated thereunder) or death, or (d) upon verification by the Committee as
such and a determination by the Committee, as a matter of grace, to allow such to be a Trigger Date, the date of an unforeseeable emergency as described in Section 409A(a)(2)(A)(vi) of the Code and the regulations and other guidance promulgated
thereunder, but only to the extent necessary to satisfy such emergency and to pay taxes reasonably anticipated as a result thereof after taking into account the extent to which such hardship is or may be relieved through reimbursement or
compensation by insurance or otherwise or by liquidation of the Grantee’s assets (to the extent the liquidation of such assets would not itself cause severe financial hardship) (determined in accordance with Section 409A(a)(2)(B)(ii)(II)
of the Code and the regulations and other guidance promulgated thereunder). 
 6.2 If the Grantee is deemed a “specified
employee” within the meaning of Section 409A of the Code, as determined by the Committee, at a time when the Grantee becomes eligible for settlement of the RSUs upon his or her “separation from service” within the meaning of
Section 409A of the Code, then to the extent necessary to prevent any accelerated or additional tax under Section 409A of the Code, such settlement will be delayed until the earlier of: (a) the date that is six months following the
Grantee’s separation from service and (b) the Grantee’s death. 
 7. No Right to Continued Service. Neither the Plan nor
this Agreement shall confer upon the Grantee any right to be retained as a Director of the Company or in any other capacity. Further, nothing in the Plan or this Agreement shall be construed to limit the discretion of the Company or the
Company’s stockholders to terminate the Grantee’s Continuous Service at any time, with or without Cause. 
 8. Adjustments. If
any change is made to the outstanding Common Stock or the capital structure of the Company, if required, the Restricted Stock Units shall be adjusted or terminated in any manner as contemplated by Section 11 of the Plan. 

9. Tax Liability. Notwithstanding any action the Company takes with respect to any or all income tax, social insurance, payroll tax, or other
tax-related withholding (“Tax-Related Items”), the ultimate liability for all Tax-Related Items is and remains the Grantee’s responsibility and the Company (a) makes no representation or undertakings regarding the
treatment of any Tax-Related Items in connection with the grant, vesting or 

  
 3 

 
settlement of the Restricted Stock Units or the subsequent sale of any shares; and (b) does not commit to structure the Restricted Stock Units to reduce or eliminate the Grantee’s
liability for Tax-Related Items or overall tax liability. 
 10. Confidentiality Obligations; Non-solicitation. 

10.1 In consideration of the Restricted Stock Units, the Grantee agrees and covenants not to, directly or indirectly, solicit, recruit,
attempt to hire or recruit, or induce the termination of employment of any employee of the Company or its Affiliates for 12 months following the Grantee’s termination (due to whatever reason or cause) of Continuous Service. 

10.2 If the Grantee breaches the covenant set forth in Section 10.1 or commits an intentional and non-trivial breach of any written
confidential information and/or intellectual property assignment agreement with the Company (or any intentional and non-trivial breach of fiduciary duty with regard to a matter which, but for the fact that non-employee directors have ambient
fiduciary duties to the Company and therefore are not generally asked to sign written confidential information and/or intellectual property assignment agreements with the Company, would typically have been the subject of a contractual obligation of
the Grantee under the Company’s standard form of written confidential information and/or intellectual property assignment agreements with the Company): 
 (a) all unvested Restricted Stock Units shall be immediately forfeited; and 
 (b)
the Grantee hereby consents and agrees that the Company shall be entitled to seek, in addition to other available remedies, a temporary, preliminary or permanent injunction or other equitable relief against such breach or threatened breach from any
court of competent jurisdiction, without the necessity of showing any actual damages or that money damages would not afford an adequate remedy, and without the necessity of posting any bond or other security. The aforementioned equitable relief
shall be in addition to, not in lieu of, legal remedies, monetary damages or other available forms of relief. 
 11. Compliance with Law.
The issuance and transfer of shares of Common Stock shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal and state securities laws and with all applicable requirements of any securities exchange
on which the Company’s shares of Common Stock may be listed. No shares of Common Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory agencies have been fully complied
with to the satisfaction of the Company and its counsel. 
 12. Notices. Any notice required to be delivered to the Company under this
Agreement shall be in writing and addressed to the Secretary of the Company at the Company’s 

  
 4 

 
principal corporate offices. Any notice required to be delivered to the Grantee under this Agreement shall be in writing and addressed to the Grantee at the Grantee’s address as shown in the
records of the Company. Either party may designate another address in writing (or by such other method approved by the Company) from time to time. 
 13. Governing Law. This Agreement will be construed and interpreted in accordance with the laws of the State of Delaware without regard to conflict of law principles. 

14. Interpretation. Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or the Company to the Committee
for review (provided, that if the Grantee is a member of the Committee, the Grantee shall not participate in the deliberations regarding or the vote as to such dispute). The resolution of such dispute by the Committee shall be final and binding on
the Grantee and the Company. 
 15. Restricted Stock Units Subject to Plan. This Agreement is subject to the Plan, as it may be amended
from time to time. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the
Plan, the applicable terms and provisions of the Plan will govern and prevail. 
 16. Successors and Assigns. The Company may assign any
of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee
and any assigns and will inure to the benefit of the Grantee and the Grantee’s executors, administrators and the person(s) to whom the Restricted Stock Units may be transferred by will or the laws of descent or distribution. 

17. Severability. The invalidity or unenforceability of any provision of the Plan or this Agreement shall not affect the validity or
enforceability of any other provision of the Plan or this Agreement, and each provision of the Plan and this Agreement shall be severable and enforceable to the extent permitted by law. 
 18. Discretionary Nature of Plan. The Plan is discretionary and may be amended, cancelled or terminated by the Company at any time, in its discretion. The grant of the Restricted Stock Units in
this Agreement does not create any contractual right or other right to receive any other Restricted Stock Units or other Awards in the future. Future Awards, if any, will be at the sole discretion of the Company. Any amendment, modification, or
termination of the Plan shall not constitute a change or impairment of the terms and conditions of the Grantee’s membership on the Board or of any other relationship which the Grantee may at the time have with the Company. 

19. Amendment. The Committee has the right to amend, alter, suspend, discontinue or cancel the Restricted Stock Units, prospectively or
retroactively; provided, that no such 

  
 5 

 
amendment, alteration, suspension, discontinuance or cancellation shall adversely affect the Grantee’s material rights under this Agreement without the Grantee’s consent. 

20. Section 409A. This Agreement is intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed
and interpreted in a manner that is consistent with the requirements for avoiding additional taxes or penalties under Section 409A of the Code. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits
provided under this Agreement comply with Section 409A of the Code and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of
non-compliance with Section 409A of the Code. 
 21. Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed an original but all of which together will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by facsimile transmission, by electronic mail in portable document format (.pdf), or by any
other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing an original signature. 

22. Acceptance. The Grantee hereby acknowledges receipt of a copy of the Plan and this Agreement. The Grantee has read and understands the terms
and provisions thereof, and accepts the Restricted Stock Units subject to all of the terms and conditions of the Plan and this Agreement. The Grantee acknowledges that there may be adverse tax consequences upon the vesting or settlement of the
Restricted Stock Units or disposition of the underlying shares and that the Grantee has been advised to consult a tax advisor before such vesting, settlement or disposition. 
 IN WITNESS WHEREOF, the parties hereto have executed this Restricted Stock Unit Agreement as of the Grant Date. 

 

			
	BIOCEPT, INC.
		
	By:	 	 

 
			
	 Name: 
	 	
	 Title:
	 	
		
		 	
	[DIRECTOR NAME]
		
	 	 	 

  
 6EX-10.3

 Exhibit 10.3 
 INDEMNIFICATION AGREEMENT 
 This Indemnification Agreement (this
“Agreement”), dated [DATE], is by and between Biocept, Inc., a Delaware corporation (the “Company”), and [NAME OF DIRECTOR/OFFICER] (“Indemnitee”). 

RECITALS 

WHEREAS, Indemnitee is a director or an officer of the Company; 
 WHEREAS, the board of directors of the Company (the “Board”) has determined that enhancing the ability of the Company to retain and attract as directors and officers the most capable
persons is in the best interests of the Company and that the Company therefore should seek to assure such persons that indemnification is available; and 
 WHEREAS, in recognition of the need to provide Indemnitee with substantial protection against personal liability, in order to procure Indemnitee’s continued service as a director or officer of the
Company and to enhance Indemnitee’s ability to serve the Company in an effective manner, and in order to provide such protection pursuant to express contract rights (intended to be enforceable irrespective of, among other things, any amendment
to the Company’s certificate of incorporation or bylaws (collectively, the “Constituent Documents”), any change in the composition of the Board or any change in control or business combination transaction relating to the
Company), the Company wishes to provide in this Agreement for the indemnification of, and the Advancement of Advance Expenses (as defined in Section 2 below) to, Indemnitee as set forth in this Agreement. 

NOW, THEREFORE, in consideration of the foregoing and Indemnitee’s agreement to continue to provide services to the Company, the
parties agree as follows: 
 1. Services to the Company. Indemnitee agrees to continue to serve as a director or officer
of the Company for so long as Indemnitee is duly elected or appointed, until Indemnitee tenders Indemnitee’s resignation or until Indemnitee is terminated by the Company or reaches any mandatory retirement age established by the Company, as
applicable. This Agreement shall not be deemed an employment agreement between the Company (or any of its subsidiaries or another Enterprise) and Indemnitee. Indemnitee specifically acknowledges that Indemnitee’s service to the Company or any
of its subsidiaries or another Enterprise (as defined in Section 2 below) is at will and Indemnitee may be discharged at any time for any reason, with or without cause, except as may be otherwise provided in any written employment agreement
between Indemnitee and the Company (or any of its subsidiaries or another Enterprise), other applicable formal severance policies duly adopted by the Board or, with respect to service as a director or officer of the Company, by the Company’s
Constituent Documents or Delaware law. This Agreement shall continue in force after Indemnitee has ceased to serve as a director or officer of the Company or, at the request of the Company, of any of its subsidiaries or another Enterprise, as
defined in Section 2 below. 
 2. Definitions. For purposes of this Agreement, the following terms shall have the
following meanings: 
 (a) “Advance” means to pay or reimburse as required pursuant to Section 4 or

  
 -1-

 
Section 5 hereof, or to advance discretionarily pursuant to Section 4 or Section 5 hereof. “Advancement” has a correlative meaning. 

(b) “Agreement” shall have the meaning ascribed to it in the prefatory language above. 

(c) “Beneficial Owner” has the meaning given to the term “beneficial owner” in Rule 13d-3 under the Exchange
Act. 
 (d) “Board” shall have the meaning ascribed to it in the Recitals above. 

(e) “Business Combination” means a reorganization, a merger or a consolidation. 

(f) “Change in Control” means the occurrence after the date of this Agreement of any of the following events:

 (i) Acquisition of Stock by Third Party. Any Person (as defined below) other than Claire Reiss becomes the Beneficial
Owner, directly or indirectly, of securities of the Company representing 20% or more of the Company’s Voting Securities, unless (a) the change in the relative Beneficial Ownership of the Company’s securities by any Person results
solely from a reduction in the aggregate number of outstanding Voting Securities or (b) immediately after the time of such becoming, a different Person is the Beneficial Owner, directly or indirectly, of securities of the Company representing
25% or more of the Company’s Voting Securities or (c) such becoming is pursuant to a gift by Claire Reiss, the death of Claire Reiss, the will of Claire Reiss, the laws of intestate succession as applied to the estate of Claire Reiss, or
the operation of a trust of which Claire Reiss was ever a trustee; 
 (ii) Corporate Transactions. The consummation of a
Business Combination, unless immediately following such Business Combination, (1) the Beneficial Owners of the Voting Securities of the Company immediately before such transaction beneficially own, directly or indirectly, more than 50% of the
combined voting power of the outstanding Voting Securities of the entity resulting from such transaction, (2) no Person (excluding any corporation resulting from such Business Combination) is the Beneficial Owner, directly or indirectly, of 20%
or more of the combined voting power of the then outstanding securities entitled to vote generally in the election of directors of such corporation except to the extent that such ownership existed before the Business Combination and (3) at
least a majority of the Board of Directors of the corporation (or the equivalent authority of a non-corporate Enterprise) resulting from such Business Combination were Continuing Directors (as defined below), at the time of the execution of the
initial agreement or of the action of the Board, providing for such Business Combination; 
 (iii) Change in Board of
Directors. The Continuing Directors cease for any reason to constitute at least a majority of the members of the Board; or 

(iv) Liquidation. The stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or
an agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring the Company’s current receivables or escrows due (or, if such approval is not
required, the 

  
 -2-

 
decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions). 

(g) “Claim” means: 
 (i) any threatened, pending or completed action, suit, proceeding or alternative dispute resolution mechanism, whether civil, criminal, administrative, arbitrative, investigative or other, and whether
made pursuant to federal, state or other law; or 
 (ii) any inquiry, hearing or investigation that Indemnitee determines might
lead to the institution of any such action, suit, proceeding or alternative dispute resolution mechanism. 
 (h)
“Company” shall have the meaning ascribed to it in the prefatory language above. 
 (i) “Constituent
Documents” shall have the meaning ascribed to it in the Recitals above. 
 (j) “Continuing Directors”
means, during a period of two consecutive years, not including any period before the execution of this Agreement, the individuals collectively who at the beginning of such period constituted the Board (including for this purpose any new directors
whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or
whose election or nomination for election was previously so approved). 
 (k) “Delaware Court” means the Court
of Chancery of the State of Delaware. 
 (l) “Disinterested Director” means a director of the Company who is
not and was not a party to the Claim in respect of which indemnification is sought by Indemnitee. 
 (m)
“Enterprise” means, any corporation, limited liability company, partnership, joint venture, trust or other entity. 
 (n) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 (o) “Expense Advance” means any payment of Expenses paid for, reimbursed to or advanced to Indemnitee by the Company pursuant to Section 4 or Section 5 hereof. 

(p) “Expenses” means any and all expenses, including attorneys’ and experts’ fees, court costs, transcript
costs, online research costs, discovery service provider expenses, travel expenses, duplicating, printing and binding costs, telephone charges, and all other costs and expenses incurred in connection with investigating, defending, being a witness in
or participating in (including on appeal), or preparing to defend, be a witness or participate in, any Claim. Expenses also shall include (i) Expenses incurred in connection with any appeal resulting from any Claim, including without limitation
the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and (ii) for purposes of Section 5 only, Expenses 

  
 -3-

 
incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement, by litigation or otherwise. Expenses, however, shall not
include amounts paid in settlement by Indemnitee or the amount of judgments, sanctions, penalties or fines against Indemnitee (or interest thereon). 
 (q) “Indemnifiable Event” means any event or occurrence, whether occurring before, on or after the date of this Agreement, related to the fact that Indemnitee is or was a director,
officer, employee or agent of the Company or any subsidiary of the Company, or is or was serving at the request of the Company as a director, officer, employee, member, manager, trustee or agent of another Enterprise, or by reason of an action or
inaction by Indemnitee in any such capacity (whether or not serving in such capacity at the time any Loss (as defined below) is incurred), for which indemnification can be provided under this Agreement. 

(r) “Indemnitee” shall have the meaning ascribed to it in the prefatory language above. 

(s) “Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporate law
and neither presently performs, nor in the past five years has performed, services for either: (i) the Company or Indemnitee (other than in connection with matters concerning other indemnitees under similar agreements) or (ii) any other
party to the Claim giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then
prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. 
 (t) “Losses” means any and all Expenses, damages, losses, liabilities, judgments, fines, penalties (whether civil, criminal or other), ERISA excise taxes, amounts paid or payable in
settlement, assessments, any federal, state, local or foreign taxes imposed as a result of the actual or deemed receipt of any payments under this Agreement and all other charges paid or payable in connection with investigating, defending, being a
witness in or participating in (including on appeal), or preparing to defend, be a witness or participate in, any Claim. 
 (u)
“Notification Date” shall have the meaning ascribed to it in Section 10(c) below. 
 (v) “Other
Indemnity Provisions” shall have the meaning ascribed to it in Section 14 below. 
 (w) “Person”
means any individual, corporation, firm, partnership, joint venture, limited liability company, estate, trust, business association, organization, governmental entity or other entity and includes the meaning set forth in Sections 13(d) and 14(d) of
the Exchange Act. 
 (x) “Standard of Conduct Determination” shall have the meaning ascribed to it in
Section 10(b) below. 
 (y) “Voting Securities” means any securities of the Company that vote generally in
the election of directors. 

  
 -4-

 3. Indemnification. Subject to the terms of this Agreement, the Company shall
indemnify Indemnitee, to the fullest extent permitted by the laws of the State of Delaware in effect on the date hereof, or as such laws may from time to time hereafter be amended to increase the scope of such permitted indemnification, against any
and all Losses if Indemnitee was or is or becomes a party to or participant in, or is threatened to be made a party to or participant in, any Claim by reason of or arising in part out of an Indemnifiable Event, including, without limitation, Claims
brought by or in the right of the Company, Claims brought by third parties, and Claims in which Indemnitee is solely a witness. 

4. Advancement of Expenses. Indemnitee shall have the right to Advancement by the Company, before the final disposition of any
Claim by final adjudication to which there are no further rights of appeal, of any and all Expenses actually and reasonably paid or incurred by Indemnitee being or preparing to be a defendant, non-plaintiff participant, investigation target, or
witness in connection with any Claim arising out of an Indemnifiable Event. In order to obtain Advancement pursuant to this Agreement, Indemnitee shall submit to the Company a written request therefor, including in such request such documentation
and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to Advancement. Indemnitee’s right to such Advancement is not subject to the satisfaction of any
standard of conduct. Advancement shall be made insofar as the Company determines Indemnitee is entitled to Advancement in accordance with this Agreement. Without limiting the generality or effect of the foregoing, within 10 calendar days after any
request by Indemnitee, the Company shall, in accordance with such request, (a) pay such Expenses on behalf of Indemnitee or (b) reimburse Indemnitee for such Expenses. In connection with any request for Expense Advances, Indemnitee shall
not be required to provide any documentation or information to the extent that the provision thereof would undermine or otherwise jeopardize attorney-client privilege. The Company may also, in its discretion, advance to Indemnitee funds in an amount
sufficient to pay such Expenses, as presented in a reasonable and detailed written budget delivered by Indemnitee. Execution and delivery to the Company of this Agreement by Indemnitee constitutes an undertaking by Indemnitee to repay (x) any
amounts paid, advanced or reimbursed by the Company pursuant to this Section 4 in respect of Expenses relating to, arising out of or resulting from any Claim in respect of which it shall be determined, pursuant to Section 10, following the
final disposition of such Claim, that Indemnitee is not entitled to indemnification hereunder, and (y) any amounts advanced by the Company pursuant to this Section 4 which are not in fact so spent for such purpose. No other form of
undertaking shall be required other than the execution of this Agreement. Indemnitee’s obligation to reimburse the Company for Expense Advances shall be unsecured and no interest shall be charged thereon. 

5. Indemnification for Expenses in Enforcing Rights. To the fullest extent allowable under applicable law, the Company shall also
indemnify against, and, if requested by Indemnitee, shall Advance to Indemnitee subject to and in accordance with Section 4, any Expenses actually and reasonably paid or incurred by Indemnitee in connection with any action or proceeding by
Indemnitee for (a) indemnification or reimbursement or payment of Expenses by the Company under any provision of this Agreement, or under any other agreement or provision of the Constituent Documents now or hereafter in effect relating to
Claims relating to Indemnifiable Events, and/or (b) recovery under any directors’ and officers’ liability insurance 

  
 -5-

 
policies maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification or insurance recovery, as the case may be. Indemnitee shall be
required to reimburse the Company in the event that a final judicial determination is made that such action brought by Indemnitee was frivolous or not made in good faith. 
 6. Partial Indemnity. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for a portion of any Losses in respect of a Claim related to an Indemnifiable
Event but not for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled. 
 7. Contribution in the Event of Joint Liability. To the fullest extent permissible under applicable law, if the contractual indemnification rights provided for in this Agreement are unavailable to
Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines, penalties, amounts paid
or to be paid in settlement and/or for Expenses, in connection with any Indemnifiable Event, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Indemnifiable Event in order to reflect (i) the
relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees, trustees,
fiduciaries and agents) and Indemnitee in connection with such event(s) and/or transaction(s). 
 8. Notification and Defense
of Claims. 
 (a) Notification of Claims. Indemnitee shall notify the Company in writing as soon as practicable of
any Claim which could relate to an Indemnifiable Event or for which Indemnitee could seek Expense Advances, including a brief description (based upon information then available to Indemnitee) of the nature of, and the facts underlying, such Claim.
The failure by Indemnitee to timely notify the Company hereunder shall not relieve the Company from any liability hereunder other than to the extent the Company’s ability to participate in the defense of such claim was materially and adversely
affected by such failure. 
 (b) The Company shall be entitled to participate in the defense of any Claim relating to an
Indemnifiable Event at its own expense and, except as otherwise provided below, to the extent the Company so wishes, it may assume the defense thereof (with the term “defense” understood to be used here in a broad and non-technical sense)
with counsel selected by the Company and reasonably satisfactory to Indemnitee. After notice from the Company to Indemnitee of its election to assume the defense of any such Claim, the Company shall not be liable to Indemnitee under this Agreement
or otherwise for any Expenses subsequently directly incurred by Indemnitee in connection with Indemnitee’s defense of such Claim other than reasonable costs of investigation or as otherwise provided below. Indemnitee shall have the right to
also employ his/her own legal counsel in such Claim, but all Expenses related to such counsel incurred after notice from the Company of its assumption of the defense shall be at Indemnitee’s own expense; provided, however, that if
(i) Indemnitee’s employment of his/her own legal counsel has been authorized by the Company, (ii) Indemnitee’s counsel has reasonably determined that there may be a conflict of interest between Indemnitee and the Company in the

  
 -6-

 
defense of such Claim, (iii) after a Change in Control, Indemnitee’s employment of his/her own counsel has been approved by the Independent Counsel or (iv) the Company shall not in
fact have employed counsel to assume the defense of such Claim, then Indemnitee shall be entitled to retain his/her own separate counsel (but not more than one law firm plus, if applicable, local counsel in respect of any such Claim) and all
Expenses related to such separate counsel shall be borne by the Company. Notwithstanding the foregoing, Indemnitee and all other indemnitees under similar indemnification agreements shall not be entitled to, in the aggregate, to more than one
separate-counsel law firm (plus, if applicable, one local counsel) in respect of any single or integrated Claim except to the extent that Indemnitee’s counsel has reasonably determined that there may be a conflict of interest between Indemnitee
and the other such indemnitees in the defense of such Claim. 
 9. Procedure Upon Application for Indemnification. In
order to obtain indemnification pursuant to this Agreement, Indemnitee shall submit to the Company a written request therefor, including in such request such documentation and information as is reasonably available to Indemnitee and is reasonably
necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of the Claim. Indemnification shall be made insofar as the Company determines Indemnitee is entitled to indemnification in
accordance with Section 10 below. 
 10. Determination of Right to Indemnification. 

(a) Mandatory Indemnification; Indemnification as a Witness. 

(i) Mandatory Indemnification. To the extent that Indemnitee shall have been successful on the merits or otherwise in defense of
any Claim relating to an Indemnifiable Event or any portion thereof or in defense of any issue or matter therein, including without limitation dismissal without prejudice, Indemnitee shall be indemnified against all Losses relating to such Claim
(or, as applicable, such portion, issue or matter) in accordance with Section 3 to the fullest extent allowable by law. 

(ii) Indemnification as a Witness. To the extent that Indemnitee’s involvement in a Claim relating to an Indemnifiable Event
is to prepare to serve and serve as a witness, and not as a party, Indemnitee shall be indemnified against all Losses incurred in connection therewith to the fullest extent allowable by law. 

(b) Standard of Conduct. To the extent that the provisions of Section 10(a) are inapplicable to a Claim related to an
Indemnifiable Event that shall have been finally disposed of, any determination of whether Indemnitee has satisfied any applicable standard of conduct under Delaware law that is a legally required condition to indemnification of Indemnitee hereunder
against Losses relating to such Claim and any determination that Expense Advances must be repaid to the Company (a “Standard of Conduct Determination”) shall be made as follows: 

(i) if no Change in Control has occurred, (A) by a majority vote of the Disinterested Directors, even if less than a quorum of the
Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum or (C) if there are no such Disinterested Directors, by Independent Counsel in a written

  
 -7-

 
opinion addressed to the Board, a copy of which shall be delivered to Indemnitee; and 
 (ii) if a Change in Control shall have occurred, (A) if Indemnitee so requests in writing, by a majority vote of the Disinterested Directors, even if less than a quorum of the Board or
(B) otherwise, by Independent Counsel in a written opinion addressed to the Board, a copy of which shall be delivered to Indemnitee. 
 The Company shall indemnify Indemnitee against and, if requested by Indemnitee, shall Advance to Indemnitee, within 10 calendar days of such request, any and all Expenses incurred by Indemnitee in
cooperating with the Person or Persons making such Standard of Conduct Determination. 
 (c) Making the Standard of Conduct
Determination. The Company shall use its reasonable best efforts to cause any Standard of Conduct Determination required under Section 10(b) to be made as promptly as practicable. If the Person or Persons designated to make the Standard of
Conduct Determination under Section 10(b) shall not have made a determination within 30 calendar days after the later of (A) receipt by the Company of a written request from Indemnitee for indemnification pursuant to Section 9 (the
date of such receipt being the “Notification Date”) and (B) the selection of an Independent Counsel, if such determination is to be made by Independent Counsel, or (if such determination is to be made by Independent Counsel) if
the Company unjustifiably and without good faith delays the proper initial designation of Independent Counsel, then Indemnitee shall be deemed to have satisfied the applicable standard of conduct, absent (i) a misstatement by Indemnitee of a
material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a final judicial determination that any or all such
indemnification is expressly prohibited under applicable law; provided, however, that such 30 calendar day period may be extended for a reasonable time, not to exceed an additional 15 calendar days, if the Person or Persons making such determination
in good faith requires such additional time to obtain or evaluate information relating thereto. Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement of Indemnitee to indemnification under this Agreement
shall be required to be made before the final disposition of any Claim. 
 (d) Payment of Indemnification. If, in regard
to any Losses: 
 (i) Indemnitee shall be entitled to indemnification pursuant to Section 10(a); 

(ii) no Standard of Conduct Determination is legally required as a condition to indemnification of Indemnitee hereunder; or 

(iii) Indemnitee has been determined or deemed pursuant to Section 10(b) or Section 10(c) to have satisfied the Standard of
Conduct Determination, 
 then the Company shall pay to Indemnitee, within 10 calendar days after the later of (A) the
Notification Date or (B) the earliest date on which the applicable criterion specified in clause (i), (ii) or (iii) is satisfied, an amount equal to such Losses. 

  
 -8-

 (e) Selection of Independent Counsel for Standard of Conduct Determination. If a
Standard of Conduct Determination is to be made by Independent Counsel pursuant to Section 10(b)(i), the Independent Counsel shall be selected by the Board of Directors, and the Company shall give written notice to Indemnitee advising
Indemnitee of the identity of the Independent Counsel so selected. If a Standard of Conduct Determination is to be made by the Independent Counsel pursuant to Section 10(b)(ii), the Independent Counsel shall be selected by Indemnitee, and
Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In either case, Indemnitee or the Company, as applicable, may, within 10 calendar days after receiving written notice of
selection from the other, deliver to the other a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not satisfy the criteria set forth in the
definition of “Independent Counsel” in Section 2, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the individual or firm so selected shall act as
Independent Counsel. If such written objection is properly and timely made and substantiated, (i) the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined
that such objection is without merit; and (ii) the non-objecting party may, at its option, select an alternative Independent Counsel and give written notice to the other party advising such other party of the identity of the alternative
Independent Counsel so selected, in which case the provisions of the two immediately preceding sentences, the introductory clause of this sentence and numbered clause (i) of this sentence shall apply to such subsequent selection and notice. If
applicable, the provisions of clause (ii) of the immediately preceding sentence shall apply to successive alternative selections. If no Independent Counsel that is permitted under the foregoing provisions of this Section 10(e) to make the
Standard of Conduct Determination shall have been selected within 20 calendar days after the Company gives its initial notice pursuant to the first sentence of this Section 10(e) or Indemnitee gives its initial notice pursuant to the second
sentence of this Section 10(e), as the case may be, either the Company or Indemnitee may petition the Delaware Court to resolve any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent
Counsel and/or to appoint as Independent Counsel an individual or firm to be selected by the Court or such other person as the Court shall designate, and the individual or firm with respect to whom all objections are so resolved or the individual or
firm so appointed will act as Independent Counsel. In all events, the Company shall pay all of the reasonable fees and expenses of the Independent Counsel incurred in connection with the Independent Counsel’s determination pursuant to
Section 10(b) and shall fully indemnify and hold harmless such Independent Counsel against any and all expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. 

(f) Presumptions and Defenses. 
 (i) Indemnitee’s Entitlement to Indemnification. In making any Standard of Conduct Determination, the Person or Persons making such determination shall presume that Indemnitee has satisfied
the applicable standard of conduct and is entitled to indemnification, and the Company shall have the burden of proof to overcome that presumption and establish that Indemnitee is not so entitled. Any Standard of Conduct Determination that is
adverse to Indemnitee may be challenged by Indemnitee in the Delaware Court. No determination by the Company (including by its directors or any Independent Counsel) that Indemnitee has not satisfied any applicable standard of conduct or failure by
the Company to reach such a 

  
 -9-

 
determination may be used as a defense to any legal proceedings brought by Indemnitee to secure indemnification or reimbursement or payment of Advance Expenses by the Company hereunder or create
a presumption that Indemnitee has not met any applicable standard of conduct. 
 (ii) Reliance as a Safe Harbor. For
purposes of this Agreement, and without creating any presumption as to a lack of good faith if the following circumstances do not exist, Indemnitee shall be deemed to have acted in good faith and in a manner he or she reasonably believed to be in or
not opposed to the best interests of the Company if Indemnitee’s actions or omissions to act are taken in good faith reliance upon the records of the Company, including its financial statements, or upon information, opinions, reports or
statements furnished to Indemnitee by the officers or employees of the Company or any of its subsidiaries in the course of their duties, or by committees of the Board or by any other Person (including legal counsel, accountants and financial
advisors) as to matters Indemnitee reasonably believes are within such other Person’s professional or expert competence and who has been selected with reasonable care by or on behalf of the Company. In addition, the knowledge and/or actions, or
failures to act, of any director, officer, agent or employee of the Company shall not be imputed to Indemnitee for purposes of determining the right to indemnity hereunder. However, there can be no “good faith reliance” upon records which
Indemnitee personally knew to be materially incorrect or materially incomplete. 
 (iii) No Other Presumptions. For
purposes of this Agreement, the termination of any Claim by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere or its equivalent, will not create a presumption that Indemnitee did
not meet any applicable standard of conduct or have any particular belief, or that indemnification hereunder is otherwise not permitted. 
 (iv) Defense to Indemnification and Burden of Proof. It shall be a defense to any action brought by Indemnitee against the Company to enforce this Agreement (other than an action brought to enforce
a claim for Losses incurred in defending against a Claim related to an Indemnifiable Event in advance of its final disposition) that it is not permissible under applicable law for the Company to indemnify Indemnitee for the amount claimed. In
connection with any such action or any related Standard of Conduct Determination, the burden of proving such a defense or that Indemnitee did not satisfy the applicable standard of conduct shall be on the Company. 

(v) Resolution of Claims. The Company acknowledges that if the Person or Persons making any Standard of Conduct Determination
determine that a Claim relating to an Indemnifiable Event has been settled for mere nuisance value (or even without payment of any money or other consideration), such Person or Persons making such Standard of Conduct Determination shall presume that
Indemnitee was “successful on the merits or otherwise” for purposes of Section 10(a)(i) with respect to such Claim. The Company shall have the burden of proof to overcome this presumption. 

11. Exclusions from Indemnification. Notwithstanding anything in this Agreement to the contrary, the Company shall not be
obligated to: 

  
 -10-

 (a) indemnify or Advance funds to Indemnitee for Expenses or Losses with respect to
proceedings initiated by Indemnitee, including any proceedings against the Company or its directors, officers, employees or other indemnitees and not by way of defense, except: 

(i) proceedings referenced in Section 5 above (unless a court of competent jurisdiction determines that overall each claim made by
Indemnitee in such proceeding was not made in good faith or was frivolous); or 
 (ii) where the Company has joined in or the
Board has consented to the initiation of such proceedings. 
 (b) indemnify Indemnitee if a final decision by a court of
competent jurisdiction determines that such indemnification is prohibited by applicable law. 
 (c) indemnify Indemnitee for the
disgorgement of profits arising from the purchase or sale by Indemnitee of securities of the Company in violation of Section 16(b) of the Exchange Act, or any similar successor statute, state law or other law. 

(d) indemnify or Advance funds to Indemnitee for Indemnitee’s reimbursement to the Company of any bonus or other incentive-based or
equity-based compensation previously received by Indemnitee or payment of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements under
Section 304 of the Sarbanes-Oxley Act of 2002 in connection with an accounting restatement of the Company or the payment to the Company of profits arising from the purchase or sale by Indemnitee of securities in violation of Section 306 of
the Sarbanes-Oxley Act). 
 12. Settlement of Claims. The Company shall not be liable to Indemnitee under this Agreement
for any amounts paid in settlement of any threatened or pending Claim related to an Indemnifiable Event effected without the Company’s prior written consent, which shall not be unreasonably withheld. The Company shall not settle any Claim
related to an Indemnifiable Event in any manner that would impose any Losses on Indemnitee (i.e., that would not be borne entirely by the Company or by some Person unaffiliated with Indemnitee) without Indemnitee’s prior written consent. The
Company shall not, without the prior written consent of Indemnitee, effect any settlement of any Claim relating to an Indemnifiable Event which Indemnitee is or could have been a party to unless such settlement includes a complete and unconditional
release of Indemnitee from all liability on all claims that are the subject matter of such Claim, does not involve any admission of fault or liability on behalf of Indemnitee, and does not directly or proximately limit Indemnitee’s legal right
to engage in any act or activity (or to refrain from doing any act or activity) in the future. 
 13. Duration. All
agreements and obligations of the Company contained herein shall continue during the period that Indemnitee is a director, officer, employee or agent of the Company or any subsidiary of the Company (or is serving at the request of the Company as a
director, officer, employee, member, trustee or agent of another Enterprise) and shall continue thereafter (i) so long as Indemnitee may be subject to any possible Claim relating to an Indemnifiable Event (including any rights of appeal
thereto) and (ii) throughout the pendency of any proceeding (including any rights of 

  
 -11-

 
appeal thereto) commenced by Indemnitee to enforce or interpret his or her rights under this Agreement, even if, in either case, he or she may have ceased to serve in such capacity at the time of
any such Claim or proceeding. 
 14. Non-Exclusivity. The rights of Indemnitee hereunder will be in addition to any other
rights Indemnitee may have under the Constituent Documents, the law of the State of Delaware, any other contract or otherwise (collectively, “Other Indemnity Provisions”); provided, however, that (a) to the extent that
Indemnitee otherwise would have any greater right to indemnification under any Other Indemnity Provision, Indemnitee will be deemed to have such greater right hereunder and (b) to the extent that any change is made to any Other Indemnity
Provision which permits any greater right to indemnification than that provided under this Agreement as of the date hereof, Indemnitee will be deemed to have such greater right hereunder. The assertion or employment of any right or remedy hereunder,
or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. 
 15. Liability
Insurance. For the duration of Indemnitee’s service as a director or officer of the Company, and thereafter for so long as Indemnitee shall be subject to any pending Claim relating to an Indemnifiable Event, the Company shall use
commercially reasonable efforts (taking into account the scope and amount of coverage available relative to the cost thereof) to continue to maintain in effect policies of directors’ and officers’ liability insurance providing coverage
that is at least substantially comparable in scope and amount to that provided by the Company’s current policies of directors’ and officers’ liability insurance. In all policies of directors’ and officers’ liability
insurance maintained by the Company, Indemnitee shall be named as an insured in such a manner as to provide Indemnitee the same rights and benefits as are provided to the most favorably insured of the Company’s directors, if Indemnitee is a
director, or of the Company’s officers, if Indemnitee is an officer (and not a director) by such policy. Upon request, the Company will provide to Indemnitee copies of all directors’ and officers’ liability insurance applications,
binders, policies, declarations, endorsements and other related materials. 
 16. No Duplication of Payments. The Company
shall not be liable under this Agreement to make any payment to Indemnitee in respect of any Losses to the extent Indemnitee has otherwise received payment under any insurance policy, the Constituent Documents, Other Indemnity Provisions or
otherwise (including from another Enterprise) of the amounts otherwise indemnifiable by the Company hereunder; provided that the foregoing shall not affect the rights of Indemnitee or the Fund Indemnitors (as defined below) as set forth in
Section 17. 
 17. Primacy of Indemnification. The Company hereby acknowledges that Indemnitee has or may have in
the future certain rights to indemnification, advancement of expenses and/or insurance provided by entities and/or organizations (and certain of their affiliates) other than the Company or the Company’s insurers or affiliates (collectively, the
“Fund Indemnitors”). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to Indemnitee are primary and any obligation of the Fund Indemnitors to Advance expenses or to provide
indemnification for the same expenses or liabilities incurred by Indemnitee are secondary), (ii) that it shall be required to Advance the full amount of Advance Expenses incurred by Indemnitee and (iii) that it shall be liable for the full
amount of all Losses to the extent legally permitted and as required by the terms of this Agreement, the Constituent 

  
 -12-

 
Documents and/or Other Indemnity Provisions, without regard to any rights Indemnitee may have against the Fund Indemnitors. The Company irrevocably waives, relinquishes and releases the Fund
Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of
Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or
payment to all of the rights of recovery of Indemnitee against the Company. The Company and Indemnitee agree that the Fund Indemnitors are express third party beneficiaries of the terms of this Section 17. 

18. Subrogation. In the event of payment to Indemnitee under this Agreement, the Company shall be subrogated to the extent of such
payment to all of the rights of recovery of Indemnitee (other than against the Fund Indemnitors). Indemnitee shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of such
documents necessary to enable the Company effectively to bring suit to enforce such rights. 
 19. Amendments; Waivers.
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be binding unless in the form of a writing signed by the
party against whom enforcement of the waiver is sought, and no such waiver shall operate as a waiver of any other provisions hereof (whether or not similar), nor shall such waiver constitute a continuing waiver. Except as specifically provided
herein, no failure to exercise or any delay in exercising any right or remedy hereunder shall constitute a waiver thereof. 

20. Enforcement and Binding Effect. 
 (a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve (or to continue to serve) as a
director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company. 
 (b) Without limiting any of the rights of Indemnitee under any Other Indemnity Provisions as they may be amended from time to time, this Agreement constitutes the entire agreement between the parties
hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that if Indemnitee was party
to an Indemnity Agreement with the Company’s California predecessor, then both this Agreement and such Indemnity Agreement shall continue to apply, with any direct inconsistency between the two resolved by giving Indemnitee “the better of
both worlds” to the extent consistent with applicable law. 
 (c) This Agreement shall be binding upon and inure to the
benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the
Company), assigns, spouses, administrators, executors, legatees, heirs and personal and legal representatives. The Company shall require and cause any successor (whether 

  
 -13-

 
direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or (if deemed to be less than substantially all) a majority of the business and/or assets of the
Company, by written agreement in form and substances satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession
had taken place. 
 21. Severability. The provisions of this Agreement shall be severable in the event that any of the
provisions hereof (including any portion thereof) are held by a court of competent jurisdiction to be invalid, illegal, void or otherwise unenforceable, and the remaining provisions shall remain enforceable to the fullest extent permitted by law.
Upon such determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a
mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible. 
 22. Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if delivered by hand, or if mailed by certified or
registered mail (with postage prepaid): 
 (a) if to Indemnitee, to the address set forth on the signature page hereto.

 (b) if to the Company, to: 
 Biocept, Inc. 
 Attn: Chief Financial Officer 

5810 Nancy Ridge Drive 
 San Diego, California 92121 
 Notice of change of address shall be effective only
when given in accordance with this Section. All notices complying with this Section shall be deemed to have been received on the date of hand delivery or on the third business day after mailing. 

23. Governing Law and Forum. This Agreement shall be governed by and construed and enforced in accordance with the laws of the
State of Delaware applicable to contracts made and to be performed in such state without giving effect to its principles of conflicts of laws. The Company and Indemnitee hereby irrevocably and unconditionally: (a) agree that any action or
proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court and not in any other state or federal court in the United States or any other country, (b) consent to submit to the exclusive
jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement and (c) waive, and agree not to plead or make, any claim that the Delaware Court lacks venue or that any such action
or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum. 
 24. Headings. The
headings of the sections and paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction or interpretation thereof. 

  
 -14-

 25. Counterparts. This Agreement may be executed in counterparts, each of which shall
for all purposes be deemed to be an original, but all of which together shall constitute one and the same Agreement. 

[Remainder of Page Intentionally Left Blank; Signature Page Follows] 

  
 -15-

 IN WITNESS WHEREOF, the parties hereto have executed this Indemnification Agreement as of
the date first above written. 
  

			
	COMPANY:
	
	BIOCEPT, INC.
		
	By: 	 	 

 
			
	Name: 	 	 

 
			
	Its: 	 	 

  

			
	INDEMNITEE:
	
	[NAME]
		
	 	 	 
		
	 	 	 
		 	(Print Name)
		
	Address:	 	 
		
		 	 
		
		 	 

 [Signature Page to Indemnification Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}]]